Europese Unie - IJslands - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry sjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).

Europese Unie - IJslands - EMA (European Medicines Agency)

eli lilly nederland b.v. - duloxetin - anxiety disorders; diabetic neuropathies; depressive disorder, major - psychoanaleptics, - meðferð við alvarlegri þunglyndisröskun. meðferð við útlægum taugakvillaverkjum í sykursýki. meðferð almenn kvíða. cymbalta er ætlað í fullorðnir.

Europese Unie - IJslands - EMA (European Medicines Agency)

virbac s.a. - hydrocortisone aceponate - barksterar, húðsjúkdómar - hundar - til meðferðar við bólgu og kláða húðhúð hjá hundum. for alleviation of clinical signs associated with atopic dermatitis in dogs.

Europese Unie - IJslands - EMA (European Medicines Agency)

emdoka bvba - halófúgínón laktat - halofuginone, Önnur frumudýraeyðandi lyfjum - kálfar, nýfætt - Í nýfætt kálfa:fyrirbyggja niðurgangur vegna greind cryptosporidium parvum sýkingu, í bæjum með sögu cryptosporidiosis. gjöf ætti að byrja á fyrstu 24 til 48 klst. lækkun niðurgangur vegna greind cryptosporidium sýkingu parvum. gjöf ætti að hefjast innan 24 klukkustunda eftir að niðurgangur hefst. Í báðum tilvikum hefur verið sýnt fram á minnkun á útskilnaði oocysts.

Europese Unie - IJslands - EMA (European Medicines Agency)

esteve pharmaceuticals, s.a. - duloxetin - anxiety disorders; depressive disorder, major; diabetic neuropathies - psychoanaleptics, - meðferð helstu þunglyndi;meðferð sykursýki útlæga taugaverkir;meðferð almenn kvíða;xeristar er ætlað í fullorðnir.

Europese Unie - IJslands - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing ltd - imidacloprid, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). dýralyfið er hægt að nota sem hluti af meðferðaráætlun fyrir húðsjúkdóm í húðflóa (fad).  for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis).  for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). dýralyfið er hægt að nota sem hluti af meðferðaráætlun fyrir húðsjúkdóm í húðflóa (fad).

IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - duloxetinum hýdróklóríð - magasýruþolið hart hylki - 30 mg

IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - duloxetinum hýdróklóríð - magasýruþolið hart hylki - 60 mg

Europese Unie - IJslands - EMA (European Medicines Agency)

virbac s.a. - halofuginone - krabbamein - kálfar, nýfætt - in new born calves:- prevention of diarrhoea due to diagnosed cryptosporidium parvum, in farms with history of cryptosporidiosis,administration should start in the first 24 to 48 hours of age- reduction of diarrhoea due to diagnosed cryptosporidium parvum. gjöf ætti að hefjast innan 24 klukkustunda eftir að niðurgangur hefst. Í báðum tilvikum hefur verið sýnt fram á minnkun á útskilnaði oocysts.

IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 1 g